Clinical Trial

Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy

Name: Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy — clinical trial record (NCT07658976)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

Individual-Level Randomized Controlled Trial of an Integrated Strategy of HIV pre-exposure prophylaxis (PrEP) and sexually transmitted infection (STI) post-exposure prophylaxis (PEP) for Young Men

Trial Details

NCT Number	NCT07658976
Lead Sponsor	HIV Prevention Trials Network Collaborators: National Institute of Allergy and Infectious Diseases (NIAID), Gilead Sciences, ViiV Healthcare
Conditions	HIV Infection, Sexually Transmitted Infection
Enrollment	400 participants
Start Date	2026-09-01
Primary Completion	2029-09-01 (estimated)
Study Completion	2029-09-01 (estimated)
Updated on ClinicalTrials.gov	2026-06-22